Health Trials

About this trial

This observational cohort study aims to track longitudinal changes in body composition, including skeletal muscle mass and fat distribution, in patients diagnosed with breast cancer. Following primary surgery and adjuvant therapy, participants will be monitored over a 2-year period.

The primary objective is to evaluate the natural progression of skeletal muscle mass index (SMI) and metabolic changes in this population. By conducting serial measurements, this study seeks to characterize the longitudinal trends in muscle loss and body composition shifts post-treatment, providing data to better understand the physiological impact of the cancer recovery process.

Eligibility criteria

Qualifiers

>18 years of age

Diagnosed with stage I-III non-metastatic breast cancer within 12 months of diagnosis

Scheduled for surgery, chemotherapy, with or without radiotherapy or targeted therapy.

Disqualifiers

Women diagnosed with metastatic (stage IV) breast cancer

Women planning to move away from the area or be away for more than 6 months during the study period

Women planning to become pregnant during the study period

Implantable devices (e.g., pacemaker, nerve stimulator) or surgical implants (e.g., total hip or knee replacements)

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

100 Participants
are grouped into 1 trial group

Locations

1
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation231, New Taipei CityXindian Dist, Taiwan

Sponsors and collaborators

Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation

Lead sponsor

Source ClinicalTrials.gov